Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Cardiology Cases|March 14, 2024
Takotsubo syndrome associated with coronary microvascular dysfunction: A case studyShohei Ikeda, Morihiko Takeda, Koichi Sato, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2021
FAD-dependent C-glycoside-metabolizing enzymes in microorganisms: Screening, characterization, and crystal structure analysisTakuto Kumano, Sanae Hori, Satomi Watanabe, et al.
Molecular Cancer Therapeutics|August 26, 2017
T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non-Small Cell Lung CancerSatomi Watanabe, Takeshi Yoshida, Hisato Kawakami, et al.
Cancer Medicine|February 1, 2019
Targeting of the HER2/HER3 signaling axis overcomes ligand-mediated resistance to trastuzumab in HER2-positive breast cancerSatomi Watanabe, Kimio Yonesaka, Junko Tanizaki, et al.
Investigational New Drugs|February 10, 2016
Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's diseaseSatomi Watanabe, Masayuki Takeda, Takayuki Takahama, et al.
Oncogene|October 11, 2018
An HER3-targeting antibody-drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLCKimio Yonesaka, Naoki Takegawa, Satomi Watanabe, et al.
Cancer Science|November 4, 2018
Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancerSatomi Watanabe, Hidetoshi Hayashi, Koji Haratani, et al.
Thoracic Cancer|December 10, 2022
Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case reportKana Fujimoto, Satomi Watanabe, Yuto Yasuda, et al.
Oncotarget|December 15, 2015
HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancerNaoki Takegawa, Kimio Yonesaka, Kazuko Sakai, et al.
Investigational New Drugs|November 4, 2022
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 studyToshio Shimizu, Kazuhiko Nakagawa, Hidetoshi Hayashi, et al.
Pageof 3